IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone ...

IRVINE, Calif.--(BUSINESS WIRE)--CG Oncology, Inc. today announced the close of an oversubscribed $105 million crossover financing round, co-led by new investors Foresite Capital and TCGX, with ...